Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

CARBOPLATIN - REFERENCE SPECTRUM (N/A)

CARBOPLATIN - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
Carmustine - reference spectrum

Carmustine - reference spectrum

NA

DISCOVER
CARMUSTINE IMPURITY A CRS (30MG)

CARMUSTINE IMPURITY A CRS (30MG)

2214-72-4

DISCOVER
CASEIN BRP (100 G)

CASEIN BRP (100 G)

9000-71-9

DISCOVER
CEFACLOR CRS (100 MG)

CEFACLOR CRS (100 MG)

70356-03-5

DISCOVER
DELTA-3-CEFACLOR CRS (15 MG)

DELTA-3-CEFACLOR CRS (15 MG)

152575-13-8

DISCOVER
CEFADROXIL CRS (150 MG)

CEFADROXIL CRS (150 MG)

66592-87-8

DISCOVER
CEFALEXIN MONOHYDRATE CRS (150 MG)

CEFALEXIN MONOHYDRATE CRS (150 MG)

23325-78-2

DISCOVER
CEFALOTIN SODIUM CRS (170 MG)

CEFALOTIN SODIUM CRS (170 MG)

58-71-9

DISCOVER
CEFAMANDOLE NAFATE CRS (125 MG)

CEFAMANDOLE NAFATE CRS (125 MG)

42540-40-9

DISCOVER
CEFATRIZINE PROPYLENE GLYCOL CRS (150 MG)

CEFATRIZINE PROPYLENE GLYCOL CRS (150 MG)

57235-40-2

DISCOVER
CEFATRIZINE IMPURITY A CRS (60 MG)

CEFATRIZINE IMPURITY A CRS (60 MG)

NA

DISCOVER